January 04, 2025 05:17 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow | Punjab cop dismissed for facilitating TV interview of Larence Bishnoi while in custody | 'Not Veer Savarkar', Congress student wing demands Delhi college be named after Manmohan Singh | 'Cowardly': PM Modi condemns New Orleans terrorist attack that killed 15 | Prashant Kishor starts fast unto death over Bihar Public Service Commission prelims cancellation demand | Bangladesh court denies bail to arrested Hindu monk Chinmoy Krishna Das
Covavax | SII
Image Credit: twitter.com/adarpoonawalla

'A new milestone has been reached', says Serum Institute as it starts production of first batch of Covavax

| @indiablooms | Jun 26, 2021, at 06:18 am

Pune/IBNS: The Serum institute of India, which started manufacturing the first batch of Novavax's Covid-19 vaccine in India under the name Covavax, said "a new milestone has been reached".

The vaccine developed by the American pharma is more than 90 per cent effective against coronavirus, the company has claimed.

Adar Poonawalla, the CEO Of the SII, this afternoon tweeted: "Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune. The vaccine has great potential to protect our future generations below the age of 18. Trials are ongoing. Well done team @seruminstindia! (sic)." 

The Serum Institute of India, which is the largest vaccine producer in the world, is already manufacturing Covid-19 vaccine - Covishield.

According to NDTV, SII is likely to start Covovax trials for children next month.

India has not cleared a Covid-19 vaccine for children yet. However, clinical trials of Bharat Biotech's Covaxin have been launched for children.

Currently, India is using three vaccines - Covaxin, Covishield and Russia's Sputnik V - to inoculate the population above 18 in the country.

Covavax is likely to be launched by September though Poonawalla had earlier hoped to launch the vaccine in June.

SII has also received drug regulator DCGI's approval to analyse and then manufacture Sputnik V at its Pune plant.

Meanwhile, Novavax has said its vaccine has "demonstrated 100 per cent protection against moderate and severe disease, 90.4 per cent efficacy overall" in a study involving 29,960 participants across 119 sites in the U.S. and Mexico, said an NDTV report.

The study was focussed on evaluating the "efficacy, safety and immunogenicity" of the vaccine, it said.

It had also underscored that it intended to seek the drug regulator's approval by the third quarter of 2021.

"Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines," said Stanley C. Erck, Novavax's president and chief executive, according to NDTV.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.